Medium materiality6/10
Baird Raises Biohaven Price Target to $48
Why it may matterVerify against the original reporting
The target implies substantial upside, but the signal rests on a single analyst opinion.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Baird raised its BHVN price target to $48, well above the reported price of $15.02. This is a bullish analyst view, though a target is an opinion rather than a forecast guarantee.
- Baird raised its BHVN target to $48 from an unspecified prior level.
- Reported price: $15.02.
Key facts
- 01
Target: $48
- 02
Posted price: $15.02
- 03
Analyst firm: Robert W. Baird
- 04
Analyst: Brian Skorney
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.